Docosahexaenoic Acid Alleviates Trimethylamine-N-oxide-mediated Impairment of Neovascularization in Human Endothelial Progenitor Cells

• Published in: Nutrients Vol. 15; no. 9; p. 2190
• Main Authors: Syu, Jia-Ning, Lin, Hung-Yu, Huang, Tun Yu, Lee, Der-Yen, Chiang, En-Pei Isabel, Tang, Feng-Yao
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 04.05.2023; MDPI
• Subjects: angiogenesis; Antibodies; atherosclerosis; blood circulation; bone marrow; Cell culture; Cell growth; Disease prevention; docosahexaenoic acid; endothelial nitric oxide synthase; glutamate-cysteine ligase; Glutathione; humans; intestinal microorganisms; Kinases; Metabolites; microRNA; MicroRNAs; Nitric oxide; Phosphorylation; Plasmids; Proteins; Reagents; risk factors; stem cell factor; Stem cells; tissue repair; United States > US; trimethylamine-N-oxide; endothelial nitric oxide synthase; microRNA 221; docosahexaenoic acid; endothelial progenitor cells; glutathione
• ISSN: 2072-6643; 2072-6643
• DOI: 10.3390/nu15092190

Background: Human endothelial progenitor cells (hEPCs), originating from hemangioblasts in bone marrow (BM), migrate into the blood circulation, differentiate into endothelial cells, and could act as an alternative tool for tissue regeneration. In addition, trimethylamine-N-oxide (TMAO), one of the gut microbiota metabolites, has been identified as an atherosclerosis risk factor. However, the deleterious effects of TMAO on the neovascularization of hEPCs have not been studied yet. Results: Our results demonstrated that TMAO dose-dependently impaired human stem cell factor (SCF)-mediated neovascularization in hEPCs. The action of TMAO was through the inactivation of Akt/endothelial nitric oxide synthase (eNOS), MAPK/ERK signaling pathways, and an upregulation of microRNA (miR)-221. Docosahexaenoic acid (DHA) could effectively inhibit the cellular miR-221 level and induce the phosphorylation level of Akt/eNOS, MAPK/ERK signaling molecules, and neovascularization in hEPCs. DHA enhanced cellular amounts of reduced form glutathione (GSH) through an increased expression of the gamma-glutamylcysteine synthetase (γ-GCS) protein. Conclusions: TMAO could significantly inhibit SCF-mediated neovascularization, in part in association with an upregulation of miR-221 level, inactivation of Akt/eNOS and MAPK/ERK cascades, suppression of γ-GCS protein, and decreased levels of GSH and GSH/GSSG ratio. Furthermore, the DHA could alleviate the detrimental effects of TMAO and induce neovasculogenesis through suppression of miR-221 level, activation of Akt/eNOS and MAPK/ERK signaling cascades, increased expression of γ-GCS protein, and increment of cellular GSH level and GSH/GSSG ratio in hEPCs.